Certificates of analysis (CoA)
On saleLOT #NL20261003
3 Oct 2026 · Janoshik
KPV
C-terminal tripeptide of α-MSH (Lys-Pro-Val) studied in inflammation research.
KPV
10 mg · 35,90 €
They received their order
Photos sent by our customers when their parcel arrived.
Description
KPV is a tripeptide (Lys-Pro-Val) corresponding to the C-terminal fragment of α-MSH, studied as a research tool for modulation of the NF-κB inflammatory pathway in laboratory models. Supplied lyophilised with an independent certificate of analysis. Intended exclusively for scientific research in the laboratory — not intended for human consumption.
Research peptides — Research Use Only
- Not for human consumption
- Not for the diagnosis, treatment or prevention of any disease
Related products
Reconstitution calculator
Pre-filled for this peptide. Adjust the water added and target dose to get the volume to draw.
Calculation result
Draw the syringe to
5
units
Volume
0.05
mL
Concentration
5
mg/mL
Draws / vial
40
Level on a graduated syringe 1 mL (100 U)
Syringe size
Target dose
the amount of peptide targeted
0.25 mg
0.25 mg = 250 mcg (µg)
Vial dosage
total peptide mass, in mg
10 mg
Bacteriostatic water
reconstitution volume, in mL
2 mL
KPV — Research protocol
Anti-inflammatory tripeptide (Lys-Pro-Val)
- Dose (study protocol)
- Nanomolar concentrations (in vitro)
- Frequency
- N/A (in-vitro research)
- Duration (published studies)
- N/A
Source : Dalmasso et al., Gastroenterology 2008 (PMID 18061177)
C-terminal fragment of α-MSH, studied for NF-κB modulation. No established human dosage.
This data comes from published studies compiled for informational purposes for laboratory professionals. No dose is recommended. Not intended for human consumption or animal use.
Read the full analysis KPVGet your complete protocol
Personalised numeric summary + a printable step-by-step reconstitution procedure. We email it to you as a PDF.
How It Works
1. Concentration
Divide vial amount (mcg) by water volume (mL) to get concentration (mcg/mL).
2. Volume needed
Divide desired dose by concentration to get injection volume in mL.
3. Syringe units
Multiply mL × 100 to get U-100 syringe units (IU).
Example
- 5 mg vial + 2 mL water = 2.5 mg/mL
- Want 250 mcg (0.25 mg)?
- 0.25 ÷ 2.5 = 0.1 mL
- 0.1 mL = 10 units on a U-100 syringe
Research Use Only
This calculator is for research purposes only. Not medical advice.
Common Conversions
- 1 mg
- 1,000 mcg
- 500 mcg
- 0.5 mg
- 250 mcg
- 0.25 mg
- 100 mcg
- 0.1 mg
Syringe Units
- 0.3 mL syringe
- 30 units
- 0.5 mL syringe
- 50 units
- 1.0 mL syringe
- 100 units
Volumetric conversion tool for laboratory handling. Not any human or animal administration advice. Research use only.
Why this research peptide
α-MSH fragment
Lys-Pro-Val tripeptide corresponding to the C-terminal fragment of the α-MSH hormone, studied as an anti-inflammatory reagent.
NF-κB pathway
Documented in vitro for inhibition of NF-κB pathway activation and reduction of pro-inflammatory cytokines.
Cellular transport
Studied for its cellular uptake via the PepT1 transporter in laboratory models.
Verified purity
HPLC + mass spectrometry analysis by an independent laboratory, certificate included with each batch.
Long-term storage
Lyophilised form stable up to 24 months at -20°C for prolonged laboratory storage.
Discreet logistics
Shipped from the EU, delivery within 1–2 days, tracking included and neutral packaging.
What is KPV?
KPV is a tripeptide (Lys-Pro-Val) corresponding to the C-terminal fragment of α-MSH. It is used as a reagent to study inflammation modulation in laboratory models. Supplied lyophilised with an independent certificate of analysis, intended exclusively for scientific research — not intended for human consumption.
Storage & handling
Product intended exclusively for scientific research in the laboratory. Keep in its original packaging until use.
Published research data
The works below document the pharmacology of KPV. They are cited as scientific context and do not constitute a product claim.
- 1
Gastroenterology (2008) — PMID 18061177
KPV inhibits activation of the NF-κB and MAP kinase pathways and reduces pro-inflammatory cytokine secretion in vitro.
Mechanisms studied in research
The literature describes several pathways studied in vitro and in preclinical models. The items below summarise these mechanisms for information only, with no intended human use.
NF-κB pathway
Studied for inhibition of NF-κB pathway activation in cellular inflammation models.
Pro-inflammatory cytokines
Documented for reduction of pro-inflammatory cytokine secretion in preclinical models.
PepT1 transporter
Described as taken up by immune and epithelial cells via the PepT1 transporter.
Questions about this product
Who is this product intended for?
Is the product intended for human consumption?
How are batches verified?
What are the delivery times?
What payment methods are accepted?
How should a lyophilised peptide be stored?
Is the certificate of analysis provided?
PEPTIDESunderstanding before use
The clear, source-backed guide to understanding how they work, their uses, their benefits, their risks and the essential precautions — before you get started.
- How peptides really work
- Their uses and what the research says
- Reported benefits vs marketing promises
- Risks, limits and essential precautions
